96 related articles for article (PubMed ID: 6892202)
21. Studies on cis-dichlorodiammineplatinum (II) as a radiosensitizer.
Alvarez MV; Cobreros G; Heras A; Lopez Zumel MC
Br J Cancer Suppl; 1978 Jun; 3():68-72. PubMed ID: 277260
[TBL] [Abstract][Full Text] [Related]
22. Hyperthermic enhancement of cisplatin-induced generation of active oxygen radicals in a cell-free system.
Masuda H; Tanaka T; Matsushima S
Anticancer Res; 1998; 18(3A):1473-7. PubMed ID: 9673358
[TBL] [Abstract][Full Text] [Related]
23. The relevance of polar surface area (PSA) in rationalizing biological properties of several cis-diamminemalonatoplatinum(II) derivatives.
Caron G; Ermondi G; Gariboldi MB; Monti E; Gabano E; Ravera M; Osella D
ChemMedChem; 2009 Oct; 4(10):1677-85. PubMed ID: 19637156
[TBL] [Abstract][Full Text] [Related]
24. Cytostatic effects of bleomycin and cis-platinum in A549 human lung tumour cells using autofeeder conditions.
Dionet C; Coppey J
Anticancer Res; 1983; 3(4):257-62. PubMed ID: 6192754
[TBL] [Abstract][Full Text] [Related]
25. Comparative studies of DNA cross-linking and cytotoxicity in Burkitt's lymphoma cell lines treated with cis-diamminedichloroplatinum(II) and L-phenylalanine mustard.
Ducore JM; Erickson LC; Zwelling LA; Laurent G; Kohn KW
Cancer Res; 1982 Mar; 42(3):897-902. PubMed ID: 7199380
[TBL] [Abstract][Full Text] [Related]
26. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
[TBL] [Abstract][Full Text] [Related]
27. Genotoxicity of cis-PtII complex of 3-aminoflavone in comparison with cis-DDP in A549 cells evaluated by comet assay.
Kosmider B; Zyner E; Osiecka R; Ochocki J
Can J Physiol Pharmacol; 2004 May; 82(5):353-8. PubMed ID: 15213736
[TBL] [Abstract][Full Text] [Related]
28. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.
Ali-Osman F; Berger MS; Rajagopal S; Spence A; Livingston RB
Cancer Res; 1993 Dec; 53(23):5663-8. PubMed ID: 8242621
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the genotoxicity of cis-bis(3-aminoflavone)dichloroplatinum(II) in comparison with cis-DDP.
Kosmider B; Wyszynska K; Janik-Spiechowicz E; Osiecka R; Zyner E; Ochocki J; Ciesielska E; Wasowicz W
Mutat Res; 2004 Mar; 558(1-2):93-110. PubMed ID: 15036123
[TBL] [Abstract][Full Text] [Related]
30. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
Mamenta EL; Poma EE; Kaufmann WK; Delmastro DA; Grady HL; Chaney SG
Cancer Res; 1994 Jul; 54(13):3500-5. PubMed ID: 8012973
[TBL] [Abstract][Full Text] [Related]
31. Cellular accumulation and DNA platination of two new platinum(II) anticancer compounds based on anthracene derivatives as carrier ligands.
Marqués-Gallego P; Kalayda GV; Jaehde U; Dulk Hd; Brouwer J; Reedijk J
J Inorg Biochem; 2009 May; 103(5):791-6. PubMed ID: 19303143
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
33. The binding of cis-dichlorodiammineplatinum(II) to extracellular and intracellular compounds in relation to drug uptake and cytotoxicity in vitro.
Melvik JE; Dornish JM; Pettersen EO
Br J Cancer; 1992 Aug; 66(2):260-5. PubMed ID: 1503898
[TBL] [Abstract][Full Text] [Related]
34. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
[TBL] [Abstract][Full Text] [Related]
35. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and characterization of di-phenyl-tin(IV)-salicyliden-ortho-aminophenols: analysis of in vitro antitumor/antioxidant activities and molecular structures.
Beltrán HI; Damian-Zea C; Hernández-Ortega S; Nieto-Camacho A; Ramírez-Apan MT
J Inorg Biochem; 2007 Jul; 101(7):1070-85. PubMed ID: 17555822
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of P53 and BAX gene expression and induction of apoptosis and necrosis by the cis-Pt(II) complex of 3-aminoflavone in comparison with cis-diamminedichloroplatinum(II) (cis-DDP) in human lymphocytes.
Kosmider B; Zawlik I; Liberski PP; Osiecka R; Zyner E; Ochocki J; Bartkowiak J
Mutat Res; 2006 Apr; 604(1-2):28-35. PubMed ID: 16443387
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of DNA repair activity in rat-liver cells exposed to cisplatin.
Hibino Y; Kamiuchi S; Kusashio E; Sugano N
Biochem Mol Biol Int; 1996 Apr; 38(5):973-9. PubMed ID: 9132166
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of paclitaxel (taxol), cisplatin, and the combination paclitaxel-cisplatin in ovarian cancer in vitro with the ATP cell viability assay.
Untch M; Sevin BU; Perras JP; Angioli R; Untch A; Hightower RD; Koechli O; Averette HE
Gynecol Oncol; 1994 Apr; 53(1):44-9. PubMed ID: 7909786
[TBL] [Abstract][Full Text] [Related]
40. Cytostatic activity in vitro of cycloleucine, aspartic acid and glutamic acid phosphonic analogues.
Duś D; Salwa J; Mastalerz P
Arch Immunol Ther Exp (Warsz); 1980; 28(3):433-8. PubMed ID: 7447648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
